Lets hope this news can transform into a good rise in share...

Lets hope this news can transform into a good rise in share price.

"Stirling Products (ASX:STI) advises that it has recently received information from its current
Distribution partner in South Africa (Afgri Operations Pty Limited) that the MCC has approved
the application for R-salbutamol to be included under Section 36 of the Stock Remedy Act. The
approval means that Afgri, on behalf of Stirling Products, can now conduct the necessary trials
for registration and commercialisation under this Act rather than the more stringent MCC
process."

I like the fact that they have the "easier" or quicker way to commercialisation


"The approval stipulated only two areas where data was specifically required to support
the application; residue levels and dust control.
“While we acknowledge that we will need to do trials in South Africa for residue levels, we are
confident that this will not be an issue,” indicated Dr London.
Previous studies have demonstrated that the effective residue levels in meat from animals that
have been fed with R-salbutamol in the finishing stage, have a very large safety margin. Many
kilograms of meat, regardless of whether it is chicken, beef or pork, needs to be consumed each
day before getting close to the low residue levels that even humans with asthma are exposed to
every day."

Looks pretty good :-)